Related Experiment Video
Updated: May 13, 2025

LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
Unveiling LDL dynamics post-stent intervention: a deep dive into transport and accumulation
Zhenmin Fan1, Tongyu Zhan1, Xia Ye1
11School of Mechanical Engineering, Jiangsu University of Technology, Changzhou Jiangsu, China.
Cardiovascular stenting can disrupt blood flow, causing abnormal low-density lipoprotein (LDL) accumulation. This lipid buildup near stent struts increases the risk of in-stent restenosis and other adverse events.
Area of Science:
- Cardiovascular Medicine
- Biomedical Engineering
- Medical Device Research
Background:
- Endovascular stent implantation is a key cardiovascular intervention.
- Mechanisms of in-stent neoarteriosclerosis and restenosis are not fully understood.
- Stenting's impact on arterial low-density lipoprotein (LDL) transport is a potential factor in adverse outcomes.
Purpose of the Study:
- To investigate how stent implantation affects LDL distribution within the coronary artery.
- To test the hypothesis that altered LDL transport contributes to adverse clinical events post-stenting.
Main Methods:
- Numerical investigation using a lumen-wall model of the coronary artery.
- Analysis of LDL transport and concentration distribution influenced by stent presence.
Main Results:
- Stent implantation disrupts blood flow, leading to abnormal lipid accumulation on the arterial wall, especially near stent struts.
- Improper stent design (thick, closely spaced, or non-streamlined struts) worsens mechanical conditions and elevates local LDL concentration.
- Stented segments and downstream areas show increased LDL concentration.
Conclusions:
- Stent presence elevates LDL concentration within and downstream of the stented arterial segment.
- Disrupted LDL transport and accumulation near stent struts are implicated in in-stent neoarteriosclerosis and restenosis.
- Optimizing stent design and implantation technique is crucial to mitigate adverse cardiovascular events.
More Related Videos
11:13Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate
Published on: May 9, 2019
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Related Concept Videos
Receptor-mediated Endocytosis
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Inflammation
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...